Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite

The Aflac Cancer Center is pediatric cancer center that provides advanced medical treatment, through clinical trials, and offers family-centered care and a child-friendly environment. Aflac Cancer Center physicians are involved in national clinical trials and collaborative studies of the Children’s Oncology Group (COG), the National Cancer Institute, the National Institutes of Health and the Pediatric Blood and Marrow Transplant Consortium. The Aflac Cancer Center is also a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers. Children’s Healthcare of Atlanta is accredited by the American College of Radiology (ACR). Located in Atlanta, Georgia, the Aflac Cancer Center has three locations: Children’s at Egleston, Children's at Hughes Spalding and Children’s at Scottish Rite. Each location features the following services: full range of pediatric infusional and apheresis services; onsite, innovative diagnostics, cell processing laboratory and oncology pharmacy; a 20-plus-member family support team—including child life specialists, social workers, chaplains, teachers, psychologists and financial coordinators—that attends to the patient’s and family’s emotional, physical and financial well-being, as well as help the family identify and use all available resources during this difficult time.

Treatment Sites in Georgia

Clinical Trials in Georgia

Phase II/III Randomized Study of Bortezomib and Sorafenib Tosylate in Patients With De Novo Acute Myeloid Leukemia With or Without High Allelic Ratio FLT3/ITD Mutations
Cancer Type: Leukemia
Study Coordinator: Sindy Midoro


A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Cancer Type: Multiple Primaries
Study Coordinator: Sindy Midoro


A Phase I, Open-label, Dose Escalation Study of LDK378 in Pediatric Patients With Malignancies That Have a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
Cancer Type: Unknown Primary

A Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas
Cancer Type: Brain Cancer
Study Coordinator: Sindy Midoro


Biological Specimen Collection and Banking From Patients With Ewing Sarcoma
Cancer Type: Ewing Sarcoma
Study Coordinator: Sindy Midoro


Phase III Partially Randomized Study of Risk-Adapted Chemotherapy in Pediatric Patients With Newly Diagnosed Standard-Risk B-Precursor Acute Lymphoblastic Leukemia
Cancer Type: Acute Lymphoblastic Leukemia
Study Coordinator: Sindy Midoro


Phase III Randomized Study of Maintenance Chemotherapy Comprising Vincristine Sulfate, Cisplatin, Etoposide, and Cyclophosphamide Versus Observation in Pediatric Patients With Newly Diagnosed Ependymoma Following Induction Chemotherapy and Post-Operati
Cancer Type: Brain Cancer
Study Coordinator: Sindy Midoro


Phase III Randomized Study of Adding Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide to Standard Chemotherapy in Patients With Non-Metastatic Extracranial Ewing Sarcoma
Cancer Type: Brain Cancer
Study Coordinator: Sindy Midoro


Phase III Randomized Study of Standard Chemoradiotherapy With or Without Carboplatin Followed by Standard Maintenance Therapy With or Without Isotretinoin and Continuation Therapy With Isotretinoin Versus No Continuation Therapy in Pediatric Patients Wit
Cancer Type: Brain Cancer
Study Coordinator: Sindy Midoro


Phase III Study of Combination Chemotherapy in Pediatric Patients With Newly Diagnosed Hepatoblastoma
Cancer Type: Liver Cancer
Study Coordinator: Sindy Midoro


Pilot Study of Neuropsychological and Behavioral Assessment in Children With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Cancer Type: Brain Cancer
Study Coordinator: Sindy Midoro


Repository Study of Blood and Tumor Tissue Samples From Patients With Osteosarcoma
Cancer Type: Bone and Soft Tissue (including Sarcoma)
Study Coordinator: Sindy Midoro


Research Study of Clinical, Genetic, and Biological Factors as Prognostic Values in Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Cancer Type: Neuroblastoma
Study Coordinator: Sindy Midoro


Specimen Collection and Banking From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Cancer Type: Leukemia
Study Coordinator: Sindy Midoro


Study of Collection and Banking of Malignant, Borderline Malignant Neoplasms, and Related Biological Specimens from Young Patients With Cancer
Cancer Type: Leukemia
Study Coordinator: Sindy Midoro


Study of Collection and Banking of Specimens From Pediatric Patients With Brain Tumors
Cancer Type: Germ Cell Tumor
Study Coordinator: Sindy Midoro


Study of Key Late-Occurring Complications in Childhood Cancer Survivors
Cancer Type: Multiple Primaries
Study Coordinator: Sindy Midoro


Study of Long-Term Follow-Up in Patients Who Have Participated in Children's Oncology Group Studies
Cancer Type: Multiple Primaries
Study Coordinator: Sindy Midoro


Study of Renal Tumors in Pediatric Patients
Cancer Type: Kidney Cancer
Study Coordinator: Sindy Midoro


Study to Collect and Characterize Tissue Specimens From Patients With Rhabdomyosarcoma Or Non-Rhabdomyosarcoma Soft Tissue Sarcoma
Cancer Type: Bone and Soft Tissue (including Sarcoma)
Study Coordinator: Sindy Midoro